Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ozlem Tureci Insider Profile
4 Followers
Ozlem Tureci, Chief Medical Officer at BioNTech SE, holds ― shares in BioNTech SE (Ticker: BNTX). Most recently, Ozlem Tureci Sold $150,000 shares of BioNTech SE on Nov 18, 2024 for an estimated value of 15.53M.
Ozlem Tureci has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Ozlem Tureci does not currently own shares as a corporate insider.
A breakdown of Ozlem Tureci's holdings
Insider Roles
Chief Medical Officer
Roles that Ozlem Tureci holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ozlem Tureci
Ozlem Tureci's Trading History
List of latest transactions for each holding click on a transaction to see Ozlem Tureci's performance on stock
You May Also Like
Ozlem Tureci insider profile FAQ
What is the percentage of profitable transactions made by Ozlem Tureci?
The percentage of profitable transactions made by Ozlem Tureci is ―.
What is the average return per transaction made by Ozlem Tureci?
The average return per transaction made by Ozlem Tureci is ―.
What stocks does Ozlem Tureci hold?
Ozlem Tureci holds: BNTX stocks.
What was Ozlem Tureci’s latest transaction?
Ozlem Tureci latest transaction was an Informative Sell of $15.53M.
What was Ozlem Tureci's most profitable transaction?
Ozlem Tureci’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ozlem Tureci's role in BioNTech SE?
Ozlem Tureci's role in BioNTech SE is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.